Ambury Biotechnology

Ambury Biotechnology is a specialized preclinical contract research organization (CRO) headquartered in Fuzhou, China. The company provides essential services for drug discovery and development, including the operation of Specific Pathogen Free (SPF) animal facilities and the management of animal ethics committees for research validation. Ambury Biotechnology is particularly recognized for its role in supporting the development of advanced immunotherapies, such as CAR-T cell treatments and PD-1 blockade combinations for oncology indications. By providing specialized laboratory infrastructure and mouse xenograft models, the company enables academic and pharmaceutical partners to perform high-precision in vivo efficacy and safety testing.